Medicines Healthcare Products Regulatory Agency
August 24
11:03
2023
Details
The Medicines and Healthcare products Regulatory Agency (MHRA) has assessed the risk of nitrosamine formation or presence during the manufacture of human medicines and has provided guidance for manufacturers to avoid the presence of nitrosamine impurities.